Results 31 to 40 of about 6,004,355 (246)

ST2825, independent of MyD88, induces reactive oxygen species-dependent apoptosis in multiple myeloma cells

open access: yesBiochemistry and Biophysics Reports
Myeloid differentiation factor 88 (MyD88), which is a key regulator of nuclear factor kappa B (NF-κB), plays an important role in tumorigenesis in lymphoid malignancies such as Waldenstrom's macroglobulinemia (WM).
Hajime Nakamura   +3 more
doaj   +1 more source

Ramulus Cinnamomi extract attenuates neuroinflammatory responses via downregulating TLR4/MyD88 signaling pathway in BV2 cells

open access: yesNeural Regeneration Research, 2017
Ramulus Cinnamomi (RC), a traditional Chinese herb, has been used to attenuate inflammatory responses. The purpose of this study was to investigate the effect of RC extract on lipopolysaccharide (LPS)-induced neuroinflammation in BV2 microglial cells and
Huan Yang   +4 more
doaj   +1 more source

Forsythiasides: A review of the pharmacological effects

open access: yesFrontiers in Cardiovascular Medicine, 2022
Forsythiasides are a kind of phenylethanol glycosides existing in Forsythia suspensa (Thunb.) Vahl, which possesses extensive pharmacological activities.
Hong-Xuan Yang   +9 more
doaj   +1 more source

Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts

open access: yesBMC Complementary Medicine and Therapies, 2020
Background Previous studies indicate that soyasaponins may reduce inflammation via modulating toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88) signaling. However, its underlying mechanisms are still not fully understood.
Junbin Chen   +9 more
doaj   +1 more source

Regulation of human formyl peptide receptor 1 synthesis: role of single nucleotide polymorphisms, transcription factors, and inflammatory mediators. [PDF]

open access: yesPLoS ONE, 2011
The gene encoding the human formyl peptide receptor 1 (FPR1) is heterogeneous, containing numerous single nucleotide polymorphisms (SNPs). Here, we examine the effect of these SNPs on gene transcription and protein translation.
Heini M Miettinen
doaj   +1 more source

Proteomics of Acute Myeloid Leukemia [PDF]

open access: yes, 2007
Acute Myeloid Leukemia (AML) is characterized by specific cytogenetic aberrations that are strong determinants of prognostic outcome and therapeutic response.
Yaseen, Mumtaz
core   +1 more source

The granulocytic inducer C/EBPalpha inactivates the myeloid master regulator PU.1 [PDF]

open access: yes, 2003
Verschiedene Transkriptionsfaktoren spielen eine Rolle in der Entwicklung myeloischer Zellen. PU.1, ein Transkriptionsfaktor aus der ETS-Familie, ist sowohl für die Entwicklung lymphatischer als auch für die Entwicklung myeloischer Zellen von Bedeutung ...
Reddy, Venkateshwar
core   +1 more source

Prognostic significance of MyD88 expression by human epithelial ovarian carcinoma cells

open access: yesJournal of Translational Medicine, 2012
Background MyD88 is an adaptor protein for TLR-4 signaling known to mediate paclitaxel resistance in epithelial ovarian carcinoma (EOC). This study examined the clinical significance of MyD88 expression in EOC.
Zhu Yi   +4 more
doaj   +1 more source

Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia [PDF]

open access: yes, 2009
<b>Background</b>: The majority of acute myeloid leukaemia (AML) patients are over sixty years of age. With current treatment regimens, survival rates amongst these, and also those younger patients who relapse, remain dismal and novel ...
Gunther Ulrich L.   +82 more
core   +1 more source

The T-cell oncogene Tal2 is a Target of PU.1 and upregulated during osteoclastogenesis [PDF]

open access: yes, 2013
Transcription factors play a crucial role in regulating differentiation processes during human life and are important in disease. The basic helix-loop-helix transcription factors Tal1 and Lyl1 play a major role in the regulation of gene expression in the
Stefanie Herkt   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy